Drug intelligence / Profile preview

m8Δ + AAV-Pv(s25-CSP)

Development stage
Preclinical
Lead developer
Kanazawa University
Modality
Vaccines & Immunotherapeutics
Administration
Intradermal, Intramuscular
01

Overview

m8Δ + AAV-Pv(s25-CSP) is a preclinical-stage, heterologous viral-vectored multistage vaccine candidate developed for the prevention of Plasmodium vivax malaria. The vaccine platform utilizes a prime-boost regimen consisting of a highly attenuated vaccinia virus strain, LC16m8Δ (m8Δ), as the prime, followed by a recombinant adeno-associated virus (AAV) boost. The vectors harbor a fusion gene encoding the pre-erythrocytic stage antigen Plasmodium vivax circumsporozoite protein (PvCSP) and the sexual stage antigen Pvs25. This dual-antigen approach is designed to elicit robust antibody responses that provide both sterile protection against sporozoite challenge and transmission-blocking efficacy to prevent the spread of the parasite.

Other names
m8Δ/AAV-Pv(s25-CSP)m8Δ/AAV1-Pv(s25-CSP)m8Δ/AAV1-Pv(s25-CSP-VK210/247)
02

Targets

Pvs25 (Plasmodium vivax ookinete surface protein 25)CSP (Circumsporozoite protein)

Beyond the preview

Go deeper on m8Δ + AAV-Pv(s25-CSP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on m8Δ + AAV-Pv(s25-CSP).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call